Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation.
about
Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measuresEarly vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk.Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study.HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.Cardiovascular risk in juvenile idiopathic arthritis.Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial.Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
P2860
Q28079770-823DA023-C9C7-44EB-A883-E9545F8C7F45Q34409903-F97F14F7-4D04-4501-BAF0-3FEF019B6969Q34482096-A0A3B1E9-EE41-430A-9F4B-B61911A67C08Q36205262-4AE21C2D-4291-42E3-806F-AD830992A988Q36516383-97030D90-BD5C-48BF-8C98-0250675D2C4AQ38090373-7AC38FBA-BCBC-4E09-8912-FB1FFBB0B8F5Q48508157-19908818-18D4-41D3-9C9C-FBF8192B3F5CQ49282700-89F00E17-FB96-45B2-9672-74F0AC8DB323Q51174739-342B2AC3-B94A-489A-BF50-0283D78D569DQ55413719-988BE87B-1331-4B89-ABF3-B1E88DD4D447
P2860
Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular risk and rheuma ...... gate measures of inflammation.
@en
Cardiovascular risk and rheuma ...... gate measures of inflammation.
@nl
type
label
Cardiovascular risk and rheuma ...... gate measures of inflammation.
@en
Cardiovascular risk and rheuma ...... gate measures of inflammation.
@nl
prefLabel
Cardiovascular risk and rheuma ...... gate measures of inflammation.
@en
Cardiovascular risk and rheuma ...... gate measures of inflammation.
@nl
P2093
P921
P356
P1433
P1476
Cardiovascular risk and rheuma ...... gate measures of inflammation.
@en
P2093
Ann W Morgan
Jacqueline Andrews
Lukasz Kozera
P304
P356
10.1093/RHEUMATOLOGY/KER232
P577
2011-07-13T00:00:00Z